PopulAtioN health management to OPTImize Care in CKD (PANOPTIC-CKD)

通过人口健康管理优化 CKD 护理 (PANOPTIC-CKD)

基本信息

项目摘要

Millions of adults have chronic kidney disease (CKD), leading to substantial morbidity, mortality and health care costs. These effects are concentrated in patients with high-risk disease. Several provider- and system-level barriers lead to well-described gaps in care for these patients, contributing to poor outcomes. Given the growing CKD population, the relative dearth of nephrologists, and the fragmented care that high-risk patients receive, novel tools are needed to improve the quality and safety of CKD care and clinical outcomes. Population health management (PHM) improves health by aggregating and analyzing data across a population to drive consistent, evidence-based care. CKD PHM using electronic health records (EHRs) can be a sustainable strategy to overcome physician- and system-level barriers. EHR-based PHM could improve the identification of patients with high-risk CKD; increase the use of evidence-based, widely available, and cost- effective interventions; and enhance medication safety. We have developed the tools needed to implement and examine the impact of an EHR-based PHM intervention. Our multidisciplinary team has constructed a dynamic CKD registry containing real-time data and embedded metrics for identifying high-risk CKD using validated risk-prediction models, reviewing medication exposures, and monitoring processes of care. We have successfully leveraged this tool to pilot an EHR-based PHM intervention that targets the timely detection of high-risk CKD, the implementation of remote nephrology guidance to improve evidence-based CKD care, and the provision of medication safety reviews and standardized CKD patient education. The overarching aim of this proposal is to test the effectiveness of a multifaceted EHR-based PHM intervention to improve the delivery of evidence-based CKD care in high-risk patients. The University of Pittsburgh's extensive PCP network offers the ideal setting to evaluate the intervention with 330 PCPs caring for over 480,000 patients while using the Epic EHR. We will perform a 42-month pragmatic, cluster randomized controlled trial in ~1,700 patients with high-risk CKD managed by their PCPs to determine whether EHR-based PHM improves key processes of care and clinical outcomes. We hypothesize that EHR-based PHM will improve hypertension control, use of renin angiotensin aldosterone system inhibitors in patients with albuminuria, and avoidance of renally contraindicated medications (Aim 1) and delay CKD progression (Aim 2). This novel intervention benefits from customization based on PCP stakeholder feedback, executive level support from the medical center and health plan, and enthusiastic support from PCPs. This study directly responds to calls from national primary care organizations to use EHRs to implement PHM while limiting the PCP burden. CKD PHM may provide a sustainable, resourceful approach to improving CKD care, outcomes, and safety. In addition, our pragmatic cluster RCT will produce code for PHM dashboards in the most widely adopted ambulatory EHR in the US, facilitating dissemination and a potential transformation in CKD care.
数以百万计的成年人患有慢性肾脏疾病(CKD),导致大量的发病率、死亡率和死亡率

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Innovations in Population Health: Improving Outcomes for Patients with Chronic Kidney Disease.
人口健康创新:改善慢性肾病患者的治疗结果。
  • DOI:
    10.1089/pop.2023.0132
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    Jhamb,Manisha
  • 通讯作者:
    Jhamb,Manisha
Symptoms with or because of Kidney Failure?
肾衰竭引起的症状或肾衰竭引起的症状?
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Khaled A Abdel-Kader其他文献

Khaled A Abdel-Kader的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Khaled A Abdel-Kader', 18)}}的其他基金

PopulAtioN health management to OPTImize Care in CKD (PANOPTIC-CKD)
通过人口健康管理优化 CKD 护理 (PANOPTIC-CKD)
  • 批准号:
    9753212
  • 财政年份:
    2018
  • 资助金额:
    $ 60.27万
  • 项目类别:
PopulAtioN health management to OPTImize Care in CKD (PANOPTIC-CKD)
通过人口健康管理优化 CKD 护理 (PANOPTIC-CKD)
  • 批准号:
    10222661
  • 财政年份:
    2018
  • 资助金额:
    $ 60.27万
  • 项目类别:
Developing, Validating, and Implementing a CKD Predictive Model (DELVECKD)
开发、验证和实施 CKD 预测模型 (DELVECKD)
  • 批准号:
    8301548
  • 财政年份:
    2011
  • 资助金额:
    $ 60.27万
  • 项目类别:
Developing, Validating, and Implementing a CKD Predictive Model (DELVECKD)
开发、验证和实施 CKD 预测模型 (DELVECKD)
  • 批准号:
    8521270
  • 财政年份:
    2011
  • 资助金额:
    $ 60.27万
  • 项目类别:
Developing, Validating, and Implementing a CKD Predictive Model (DELVECKD)
开发、验证和实施 CKD 预测模型 (DELVECKD)
  • 批准号:
    9251971
  • 财政年份:
    2011
  • 资助金额:
    $ 60.27万
  • 项目类别:
Developing, Validating, and Implementing a CKD Predictive Model (DELVECKD)
开发、验证和实施 CKD 预测模型 (DELVECKD)
  • 批准号:
    8897359
  • 财政年份:
    2011
  • 资助金额:
    $ 60.27万
  • 项目类别:
Developing, Validating, and Implementing a CKD Predictive Model (DELVECKD)
开发、验证和实施 CKD 预测模型 (DELVECKD)
  • 批准号:
    8189595
  • 财政年份:
    2011
  • 资助金额:
    $ 60.27万
  • 项目类别:
Developing, Validating, and Implementing a CKD Predictive Model (DELVECKD)
开发、验证和实施 CKD 预测模型 (DELVECKD)
  • 批准号:
    8730137
  • 财政年份:
    2011
  • 资助金额:
    $ 60.27万
  • 项目类别:
Automated Clinical Reminders in the Care of Chronic Kidney Disease Patients
慢性肾病患者护理中的自动临床提醒
  • 批准号:
    7752254
  • 财政年份:
    2009
  • 资助金额:
    $ 60.27万
  • 项目类别:
Automated Clinical Reminders in the Care of Chronic Kidney Disease Patients
慢性肾病患者护理中的自动临床提醒
  • 批准号:
    8040949
  • 财政年份:
    2009
  • 资助金额:
    $ 60.27万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 60.27万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 60.27万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 60.27万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 60.27万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 60.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 60.27万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 60.27万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 60.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 60.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 60.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了